Use of hydroxyurea from childhood to adult age in sickle cell disease: Semen analysis

Haematologica

Volumn 93, Issue 11, 2008, Pages

  Lukusa, A K ^a   Vermylen, C ^b  

^a UNIVERSITY OF KINSHASA   (Congo)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA;

ADOLESCENT; ADULT; AZOOSPERMIA; CLINICAL ARTICLE; CRYOPRESERVATION; DRUG EFFECT; HUMAN; LETTER; MALE; MALE FERTILITY; OLIGOSPERMIA; SEMEN ANALYSIS; SICKLE CELL ANEMIA; SPERMATOGENESIS; TREATMENT DURATION;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CHILD; FERTILITY; HUMANS; HYDROXYUREA; INFERTILITY, MALE; MALE; PROGNOSIS; SEMEN; SPERMATOZOA;

EID: 55549101576     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.13659     Document Type: Letter

References (6)

1. Berthaut I, Guignedoux G, Kirsh-Noir F, De Larouziere V, Ravel C, Bachir D, et al. Infuence of sickle cell disease and treatment with hydroxyurea on sperm parameters and fertility of human males. Haematologica 2008;93:988-93.
2. Ferster A, Vermylen C, Cornu G, Buyse M, Corazza F, Delvack C, et al. Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial. Blood 2001;98:2878-9.
3. Rogers ZR, Buchan GR. Expanding the role of hydroxyurea in children with sickle cell disease. J Pediatr 2004;145:287-8.
4. Hankins JS, Ware RE, Rogers ZR, Wynn LW, Lane PA, Scott JP, et al. Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study. Blood 2005;106:2269-75.
5. De Montalembert M, Brousse V, Elie C, Bernaudin F, Shi J, Landais P. Long-term hydroxyurea treatment in children with sickle cell disease: tolerance and clinical outcomes. Haematologica 2006; 91:125-28.
6. Rowe PJ, Comhaire FH, Harcreave TB, Mahmoud AM. WHO manual for the standardized investigation, diagnosis and management of the infertile male. Cambridge University Press; 2000(91p).